Obinutuzumab, ibrutinib, and venetoclax in untreated CLL with deletion(17p)/TP53 mutation; NOTCH2 mutants promote chemo-resistance in DLBCL; and the role of DBY/HLA class II complexes in chronic GVHD
episode
Blood Podcast
not yet transcribed
Transcript
This episode hasn't been transcribed yet
Upvotes decide what gets transcribed next — 0 so far.
Sign in to upvote
Related
recent transcribed audio
The Ezra Klein Show: Jensen Huang Thinks A.I. Alarmism Has Gone Too Far
Pretty Little Episode #110
Be Upfront About How You Make Money From Your Podcast
High Stakes US-China Sit Down & Flock Surveillance Under Scrutiny | 9.25.26
Ireland collapse in Kosovo as Israel game looms
Living Breakthrough-Minded | Joel Osteen